I think Galera is waiting to see how the EOP2 meet
Post# of 72436
![](/assets/46931549/no_avatar_available_thumb.jpg)
testing of their "so-so" IV drug for OM.
They had 61 sites for 200 patients during P2. Now they are enrolling 335 patients for P3.
They may just throw in the towel after the IPIX EOP2 meeting.
Why waste all that money on nothing.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)